Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Type (IVD, LDT, Imaging), By Application (Breast Cancer, Lung Cancer), By End-use, By Test Type, By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.2 Market Definitions
1.2.1 Objective - 1
1.2.2 Objective - 2
1.2.3 Objective - 3
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 Gvr’s Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.5 Information or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 List of Primary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Product and Type Segment Snapshot
2.3 Application Segment Snapshot
2.4 End-Use and Test Type Segment Snapshot
2.5 Competitive Landscape Snapshot
Chapter 3 Cancer Diagnostics Market Variables, Trends, and Scope
3.1 Cancer Diagnostics Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Rising Prevalence Of Cancer
3.2.1.2 Technological Advancements
3.2.1.3 Rising Initiatives Undertaken By Public And Private Organizations
3.2.1.4 Extensive R&D For The Development Of Novel Testing Solutions
3.2.2 Market Restraint Analysis
3.2.2.1 High Cost Of Diagnostic Imaging
3.2.2.2 Radiation Exposure Likely To Limit Usage Of Ct Scans
3.2.2.3 Rising Adoption Of Refurbished Diagnostic Imaging Systems
3.3 Cancer Diagnostics Market Analysis Tools
3.3.1 Porter’s Five Forces Analysis
3.3.2 Macroeconomic Analysis
3.4 Market Opportunity Analysis
3.4.1 Advent Of Personalized Medicine And Companion Diagnostics
Chapter 4 Cancer Diagnostics Market: Segment Analysis, by Product, 2018 - 2030 (USD Million)
4.1 Cancer Diagnostics Market: Product Movement Analysis
4.2 Cancer Diagnostics Market Estimates & Forecast, by Product (USD Million)
4.2.1 Instruments
4.2.1.1 Pathology-based Instruments
4.2.1.1.1 Slide Staining Systems
4.2.1.1.2 Tissue Processing Systems
4.2.1.1.3 Cell Processors
4.2.1.1.4 PCR Instruments
4.2.1.1.5 NGS Instruments
4.2.1.1.6 Microarrays
4.2.1.1.7 Other Pathology-based Instruments
4.2.1.2 Imaging Instruments
4.2.1.3 Others
4.2.2 Consumables
4.2.2.1 Antibodies
4.2.2.2 Kits & reagents
4.2.2.3 Probes
4.2.2.4 Others
4.2.3 Services
Chapter 5 Cancer Diagnostics Market: Segment Analysis, by Type, 2018 - 2030 (USD Million)
5.1 Cancer Diagnostics Market: Type Movement Analysis
5.2 Cancer Diagnostics Market Estimates & Forecast, by Type (USD Million)
5.2.1 IVD
5.2.1.1 By Type
5.2.1.1.1 Diagnosis
5.2.1.1.2 Early Detection
5.2.1.1.3 Therapy Selection
5.2.1.1.4 Monitoring
5.2.1.2 By Technology
5.2.1.2.1 Polymerase Chain Reaction (PCR)
5.2.1.2.2 In Situ Hybridization (ISH)
5.2.1.2.3 Immunohistochemistry (IHC)
5.2.1.2.4 Next-generation Sequencing (NGS)
5.2.1.2.5 Microarrays
5.2.1.2.6 Flow Cytometry
5.2.1.2.7 Immunoassays
5.2.1.2.8 Other IVD Testing Technologies
5.2.2 LDT
5.2.3 IMAGING
5.2.3.1 Magnetic Resonance Imaging (MRI)
5.2.3.2 Computed Tomography (CT)
5.2.3.3 Positron Emission Tomography (PET)
5.2.3.4 Mammography
5.2.3.5 Ultrasound
5.2.3.6 Others
Chapter 6 Cancer Diagnostics Market: Segment Analysis, by Application, 2018 - 2030 (USD Million)
6.1 Cancer Diagnostics Market: Application Movement Analysis
6.2 Cancer Diagnostics Market Estimates & Forecast, by Application (USD Million)
6.2.1 Breast Cancer
6.2.2 Colorectal Cancer
6.2.3 Cervical Cancer
6.2.4 Lung Cancer
6.2.5 Prostate Cancer
6.2.6 Skin Cancer
6.2.7 Blood Cancer
6.2.8 Kidney Cancer
6.2.9 Liver Cancer
6.2.10 Pancreatic Cancer
6.2.11 Ovarian Cancer
6.2.12 Others
Chapter 7 Cancer Diagnostics Market: Segment Analysis, by End Use, 2018 - 2030 (USD Million)
7.1 Cancer Diagnostics Market: End-User Movement Analysis
7.2 Cancer Diagnostics Market Estimates & Forecast, by End Use (USD Million)
7.2.1 Hospitals
7.2.2 Laboratories
7.2.3 Others
Chapter 8 Cancer Diagnostics Market: Segment Analysis, by Test Type, 2018 - 2030 (USD Million)
8.1 Cancer Diagnostics Market: Test Type Movement Analysis
8.2 Cancer Diagnostics Market Estimates & Forecast, by Test Type (USD Million)
8.2.1 Biopsy
8.2.1.1 Fine-Needle Aspiration
8.2.1.2 Core Biopsy
8.2.1.3 Surgical Biopsy
8.2.1.4 Skin Biopsy/Punch Biopsy
8.2.1.5 Others
8.2.2 Others
Chapter 9 Cancer Diagnostics Market: Regional Estimates and Trend Analysis, by Product, By Type, By Test Type, By Application, By End-Use
9.1 Cancer Diagnostics Market: Regional Outlook
9.2 North America
9.2.1 North America Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.2.2 U.S.
9.2.2.1 Key Country Dynamics
9.2.2.2 U.S. Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.2.2.3 Target Disease: Cancer Incidence
9.2.2.4 Market And Competitive Scenario
9.2.2.5 Regulatory Framework
9.2.2.6 Reimbursement Scenario
9.2.3 Canada
9.2.3.1 Key Country Dynamics
9.2.3.2 Canada Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.2.3.3 Target Disease: Cancer Incidence
9.2.3.4 Market And Competitive Scenario
9.2.3.5 Regulatory Framework
9.2.3.6 Reimbursement Scenario
9.3 Europe
9.3.1 Europe Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.2 UK
9.3.2.1 Key Country Dynamics
9.3.2.2 UK Cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
9.3.2.3 Target Disease Prevalence
9.3.2.4 Market and Competitive Scenario
9.3.2.5 Regulatory Framework
9.3.2.6 Reimbursement Scenario
9.3.3 Germany
9.3.3.1 Key Country Dynamics
9.3.3.2 Germany Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.3.3 Target Disease Prevalence
9.3.3.4 Market And Competitive Scenario
9.3.3.5 Regulatory Framework
9.3.3.6 Reimbursement Scenario
9.3.4 France
9.3.4.1 Key Country Dynamics
9.3.4.2 France Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.4.3 Target Disease Prevalence
9.3.4.4 Market And Competitive Scenario
9.3.4.5 Regulatory Framework
9.3.4.6 Reimbursement Scenario
9.3.5 Spain
9.3.5.1 Key Country Dynamics
9.3.5.2 Spain Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.5.3 Target Disease Prevalence
9.3.5.4 Market and Competitive Scenario
9.3.5.5 Regulatory Framework
9.3.5.6 Reimbursement Scenario
9.3.6 Italy
9.3.6.1 Key Country Dynamics
9.3.6.2 Italy Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.6.3 Target Disease Prevalence
9.3.6.4 Market And Competitive Scenario
9.3.6.5 Regulatory Framework
9.3.6.6 Reimbursement Scenario
9.3.7 Denmark
9.3.7.1 Key Country Dynamics
9.3.7.2 Denmark Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.7.3 Target Disease Prevalence
9.3.7.4 Market And Competitive Scenario
9.3.7.5 Regulatory Framework
9.3.7.6 Reimbursement Scenario
9.3.8 Sweden
9.3.8.1 Key Country Dynamics
9.3.8.2 Sweden Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.8.3 Target Disease Prevalence
9.3.8.4 Market And Competitive Scenario
9.3.8.5 Regulatory Framework
9.3.8.6 Reimbursement Scenario
9.3.9 Norway
9.3.9.1 Key Country Dynamics
9.3.9.2 Norway Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.3.9.3 Target Disease Prevalence
9.3.9.4 Market And Competitive Scenario
9.3.9.5 Regulatory Framework
9.3.9.6 Reimbursement Scenario
9.3.9.7 Rest Of Europe Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.2 Japan
9.4.2.1 Key Country Dynamics
9.4.2.2 Japan Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.2.3 Target Disease Prevalence
9.4.2.4 Market and Competitive Scenario
9.4.2.5 Regulatory Framework
9.4.2.6 Reimbursement Scenario
9.4.3 China
9.4.3.1 Key Country Dynamics
9.4.3.2 China Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.3.3 Target Disease Prevalence
9.4.3.4 Market And Competitive Scenario
9.4.3.5 Regulatory Framework
9.4.3.6 Reimbursement Scenario
9.4.4 India
9.4.4.1 Key Country Dynamics
9.4.4.2 India Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.4.3 Target Disease Prevalence
9.4.4.4 Market And Competitive Scenario
9.4.4.5 Regulatory Framework
9.4.4.6 Reimbursement Scenario
9.4.5 Australia
9.4.5.1 Key Country Dynamics
9.4.5.2 Australia Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.5.3 Target Disease Prevalence
9.4.5.4 Market And Competitive Scenario
9.4.5.5 Regulatory Framework
9.4.5.6 Reimbursement Scenario
9.4.6 Thailand
9.4.6.1 Key Country Dynamics
9.4.6.2 Thailand Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.6.3 Target Disease Prevalence
9.4.6.4 Market And Competitive Scenario
9.4.6.5 Regulatory Framework
9.4.6.6 Reimbursement Scenario
9.4.7 South Korea
9.4.7.1 Key Country Dynamics
9.4.7.2 South Korea Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.4.7.3 Target Disease Prevalence
9.4.7.4 Market And Competitive Scenario
9.4.7.5 Regulatory Framework
9.4.7.6 Reimbursement Scenario
9.4.7.7 Rest Of Asia Pacific Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5 Latin America
9.5.1 Latin America Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.2 Brazil
9.5.2.1 Key Country Dynamics
9.5.2.2 Brazil Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.2.3 Target Disease Prevalence
9.5.2.4 Competitive Scenario
9.5.2.5 Regulatory Framework
9.5.2.6 Reimbursement Scenario
9.5.3 Mexico
9.5.3.1 Key Country Dynamics
9.5.3.2 Mexico Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.3.3 Target Disease Prevalence
9.5.3.4 Competitive Scenario
9.5.3.5 Regulatory Framework
9.5.3.6 Reimbursement Scenario
9.5.4 Argentina
9.5.4.1 Key Country Dynamics
9.5.4.2 Argentina Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5.4.3 Target Disease Prevalence
9.5.4.4 Competitive Scenario
9.5.4.5 Regulatory Framework
9.5.4.6 Reimbursement Scenario
9.5.4.7 Rest Of Latin America Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6是
9.6.1 MEA Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.2 South Africa
9.6.2.1 Key Country Dynamics
9.6.2.2 South Africa Cancer diagnostics market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.2.3 Target Disease Prevalence
9.6.2.4 Competitive Scenario
9.6.2.5 Regulatory Framework
9.6.2.6 Reimbursement Scenario
9.6.3 Saudi Arabia
9.6.3.1 Key Country Dynamics
9.6.3.2 Saudi Arabia Cancer diagnostics market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6.3.3 Target Disease Prevalence
9.6.3.4 Competitive Scenario
9.6.3.5 Regulatory Framework
9.6.3.6 Reimbursement Scenario
9.6.4 UAE
9.6.4.1 Key Country Dynamics
9.6.4.2 UAE Cancer diagnostics market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.4.3 Target Disease Prevalence
9.6.4.4 Competitive Scenario
9.6.4.5 Regulatory Framework
9.6.4.6 Reimbursement Scenario
9.6.5 KUWAIT
9.6.5.1 Key Country Dynamics
9.6.5.2 Kuwait Cancer diagnostics market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.5.3 Target Disease Prevalence
9.6.5.4 Competitive Scenario
9.6.5.5 Regulatory Framework
9.6.5.6 Reimbursement Scenario
9.6.5.7 Rest of MEA Cancer diagnostics market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 10 Competitive Landscape
10.1 Company Categorization
10.2 Strategy Mapping
10.2.1 New product launch
10.2.2 Partnerships
10.2.3 Acquisition
10.2.4 Collaboration
10.2.5 Funding
10.3 Company Market Share Analysis, 2022
10.4 Company Profiles
10.4.1 ABBOTT
10.4.1.1 Company Overview
10.4.1.2 Financial Performance
10.4.1.3 Product Benchmarking
10.4.1.4 Strategic Initiatives
10.4.2 GE HEALTHCARE
10.4.2.1 Company Overview
10.4.2.2 Financial Performance
10.4.2.3 Product Benchmarking
10.4.2.4 Strategic Initiatives
10.4.3 F. HOFFMANN-LA ROCHE LTD.
10.4.3.1 Company Overview
10.4.3.2 Financial Performance
10.4.3.3 Product Benchmarking
10.4.3.4 Strategic Initiatives
10.4.4 QIAGEN
10.4.4.1 Company Overview
10.4.4.2 Financial Performance
10.4.4.3 Product Benchmarking
10.4.4.4 Strategic Initiatives
10.4.5 BD
10.4.5.1 Company Overview
10.4.5.2 Financial Performance
10.4.5.3 Product Benchmarking
10.4.5.4 Strategic Initiatives
10.4.6 SIEMENS HEALTHCARE GMBH
10.4.6.1 Company Overview
10.4.6.2 Financial Performance
10.4.6.3 Product Benchmarking
10.4.6.4 Strategic Initiatives
10.4.7 THERMO FISHER SCIENTIFIC, INC.
10.4.7.1 Company Overview
10.4.7.2 Financial Performance
10.4.7.3 Product Benchmarking
10.4.7.4 Strategic Initiatives
10.4.8 HOLOGIC, INC.
10.4.8.1 Company Overview
10.4.8.2 Financial Performance
10.4.8.3 Product Benchmarking
10.4.8.4 Strategic Initiatives
10.4.9 KONINKLIJKE PHILIPS N.V. (PHILIPS)
10.4.9.1 Company Overview
10.4.9.2 Financial Performance
10.4.9.3 Product Benchmarking
10.4.9.4 Strategic Initiatives
10.4.10 ILLUMINA, INC.
10.4.10.1 Company Overview
10.4.10.2 Financial Performance
10.4.10.3 Product Benchmarking
10.4.10.4 Strategic Initiatives
Chapter 11 Conclusion

List of Tables

Table 1 List of abbreviations
Table 2 Global cancer diagnostics market, by region, 2018 - 2030 (USD Billion)
Table 3 Global cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 4 Global cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 5 Global cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 6 Global cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 7 Global cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 8 North America cancer diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 9 North America cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 10 North America cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 11 North America cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 12 North America cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 13 North America cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 14 U.S. cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 15 U.S. cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 16 U.S. cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 17 U.S. cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 18 U.S. cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 19 Canada cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 20 Canada cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 21 Canada cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 22 Canada cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 23 Canada cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 24 Europe cancer diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 25 Europe cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 26 Europe cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 27 Europe cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 28 Europe cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
表29个欧洲癌症诊断市场,通过测试type, 2018 - 2030 (USD Billion)
Table 30 UK cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 31 UK cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 32 UK cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 33 UK cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 34 UK cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 35 Germany cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 36 Germany cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 37 Germany cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 38 Germany cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 39 Germany cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 40 France cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 41 France cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 42 France cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 43 France cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 44 France cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 45 Italy cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 46 Italy cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 47 Italy cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 48 Italy cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 49 Italy cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 50 Spain cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 51 Spain cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 52 Spain cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 53 Spain cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 54 Spain cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 55 Denmark cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 56 Denmark cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 57 Denmark cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 58 Denmark cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 59 Denmark cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 60 Sweden cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 61 Sweden cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 62 Sweden cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 63 Sweden cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 64 Sweden cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 65 Norway cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 66 Norway cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 67 Norway cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
表68年挪威癌症诊断市场,年底-use, 2018 - 2030 (USD Billion)
Table 69 Norway cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 70 Asia Pacific cancer diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 71 Asia Pacific cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 72 Asia Pacific cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 73 Asia Pacific cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 74 Asia Pacific cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 75 Asia Pacific cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 76 Japan cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 77 Japan cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 78 Japan cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 79 Japan cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 80 Japan cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 81 China cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 82 China cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 83 China cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 84 China cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 85 China cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 86 India cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 87 India cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 88 India cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 89 India cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 90 India cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 91 South Korea cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 92 South Korea cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 93 South Korea cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 94 South Korea cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 95 South Korea cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 96 Thailand cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 97 Thailand cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 98 Thailand cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 99 Thailand cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 100 Australia cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 101 Australia cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 102 Australia cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 103 Australia cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 104 Australia cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 105 Australia cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 106 Latin America cancer diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 107 Latin America cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 108 Latin America cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 109 Latin America cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 110 Latin America cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 111 Latin America cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 112 Brazil cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 113 Brazil cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 114 Brazil cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 115 Brazil cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
表116年巴西癌症诊断市场, by test type, 2018 - 2030 (USD Billion)
Table 117 Mexico cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 118 Mexico cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 119 Mexico cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 120 Mexico cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 121 Mexico cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 122 Argentina cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 123 Argentina cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 124 Argentina cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 125 Argentina cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 126 Argentina cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 127 Middle East & Africa cancer diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 128 Middle East & Africa cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 129 Middle East & Africa cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 130 Middle East & Africa cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 131 Middle East & Africa cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 132 Middle East & Africa cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 133 South Africa cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 134 South Africa cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 135 South Africa cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 136 South Africa cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 137 South Africa cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 138 Saudi Arabia cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 139 Saudi Arabia cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 140 Saudi Arabia cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 141 Saudi Arabia cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 142 Saudi Arabia cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 143 UAE cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 144 UAE cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 145 UAE cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 146 UAE cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 147 UAE cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)
Table 148 Kuwait cancer diagnostics market, by product, 2018 - 2030 (USD Billion)
Table 149 Kuwait cancer diagnostics market, by type, 2018 - 2030 (USD Billion)
Table 150 Kuwait cancer diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 151 Kuwait cancer diagnostics market, by end-use, 2018 - 2030 (USD Billion)
Table 152 Kuwait cancer diagnostics market, by test type, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Cancer diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Product and type segment snapshot
Fig. 11 Application segment snapshot
Fig. 12 End-use and test type segment snapshot
Fig. 13 Competitive landscape snapshot
Fig. 14 Cancer diagnostics market value, 2022 (USD Billion)
Fig. 15 Market dynamics
Fig. 16 Incidence of most common cancers globally, 2020
Fig. 17 Porter’s five forces analysis
Fig. 18 PESTLE analysis
Fig. 19 Cancer diagnostics market: Product outlook and key takeaways
Fig. 20 Cancer diagnostics market: Product movement analysis
Fig. 21 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Pathology-based instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Slide staining systems market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Tissue processing systems market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Cell processors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 PCR instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 NGS instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Microarrays market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Other pathology-based instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Imaging instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Antibodies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Kits & reagents market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Probes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Cancer diagnostics market: Type outlook and key takeaways
Fig. 39 Cancer diagnostics market: Type movement analysis
Fig. 40 IVD market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Diagnosis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Early detection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Therapy selection market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Monitoring market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Polymerase Chain Reaction (PCR) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 In Situ Hybridization (ISH) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Immunohistochemistry (IHC) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Next-generation Sequencing (NGS) market estimates and forecast, 2018 - 2030 (USD Million)
图49芯片市场估计和预测,2018 - 2030 (USD Million)
Fig. 50 Flow cytometry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Immunoassays market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Other IVD testing technologies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 LDT market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Imaging market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Magnetic Resonance Imaging (MRI) market estimates and forecast, 2018 - 2030 (USD Million)
图56计算机断层扫描(CT)市场预期and forecast, 2018 - 2030 (USD Million)
Fig. 57 Positron Emission Tomography (PET) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Mammography market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Ultrasound market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Cancer diagnostics market: Application outlook and key takeaways
图62年癌症诊断市场应用movement analysis
Fig. 63 Breast cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Colorectal cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Cervical cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Lung cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Prostate cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Skin cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Blood cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Kidney cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 Liver cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Pancreatic cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Ovarian cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Cancer diagnostics market: End-use outlook and key takeaways
Fig. 76 Cancer diagnostics market: End-use movement analysis
Fig. 77 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Cancer diagnostics market: Test type outlook and key takeaways
Fig. 81 Cancer diagnostics market: Test type movement analysis
Fig. 82 Biopsy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 83 Fine-needle aspiration market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 Core biopsy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 85 Surgical biopsy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 86 Skin biopsy/punch biopsy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 87 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 88 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 89 Cancer Diagnostics Market revenue, by region, 2022 & 2030 (USD Million)
Fig. 90 Regional marketplace: Key takeaways
Fig. 91 Regional marketplace: Key takeaways
Fig. 92 North America cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Key country dynamics
Fig. 94 U.S. cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Cancer incidence, 2018 - 2030
Fig. 96 Ways to obtain coverage
Fig. 97 Key country dynamics
Fig. 98 Canada cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 99 Cancer incidence, 2018 - 2030
Fig. 100 Europe cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 101 Key country dynamics
Fig. 102 UK cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 103 Cancer incidence, 2018 - 2030
Fig. 104 Key country dynamics
Fig. 105 Germany cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 106 Cancer incidence, 2018 - 2030
Fig. 107 Key country dynamics
Fig. 108 France cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 109 Cancer incidence, 2018 - 2030
Fig. 110 Key country dynamics
Fig. 111 Spain cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 112 Cancer incidence, 2018 - 2030
Fig. 113 Key country dynamics
Fig. 114 Italy cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
图115癌症发病率,2018 - 2030
Fig. 116 Key country dynamics
图117年丹麦癌症诊断市场estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 118 Target disease prevalence
Fig. 119 Key country dynamics
Fig. 120 Sweden cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 121 Five most common cancers in Sweden
Fig. 122 Key country dynamics
Fig. 123 Norway cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 124 Number of new cancer cases in 2020, both sexes, all ages
Fig. 125 Rest of Europe cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 126 Asia Pacific cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 127 Key country dynamics
Fig. 128 Japan cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 129 Cancer incidence, 2018 to 2030
Fig. 130 Key country dynamics
Fig. 131 China cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 132 Cancer incidence, 2018 to 2030
Fig. 133 China regulatory details
Fig. 134 Key country dynamics
Fig. 135 India cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 136 Cancer incidence, 2018 to 2030
Fig. 137 Key country dynamics
Fig. 138 Australia cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 139 Cancer incidence, 2018 to 2030
Fig. 140 Key country dynamics
Fig. 141 Thailand cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 142 Cancer incidence, 2020 to 2030
Fig. 143 Key country dynamics
Fig. 144 South Korea cancer diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 145 Cancer incidence 2018 to 2030
Fig. 146 South Korean regulations in four hierarchical orders
Fig. 147 South Korea reimbursement scenario
图148年亚太地区的癌症诊断arket estimates and forecast, 2018 - 2030 (USD Million)
Fig. 149 Latin America cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 150 Key country dynamics
Fig. 151 Brazil cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 152 Estimated number of new cancer cases in Brazil
Fig. 153 Key country dynamics
Fig. 154 Mexico cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 155 Estimated number of new cancer cases in Mexico
Fig. 156 Key country dynamics
Fig. 157 Argentina cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 158 Estimated number of new cancer cases in Argentina
Fig. 159 Rest of Latin America cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 160 MEA cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 161 Key country dynamics
Fig. 162 South Africa cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 163 Cancer prevalence-2018 - 2030
Fig. 164 Key country dynamics
Fig. 165 Saudi Arabia cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 166 Cancer prevalence-2018 - 2030
Fig. 167 Key country dynamics
Fig. 168 UAE cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 169 Cancer prevalence 2018 - 2030
Fig. 170 Key country dynamics
Fig. 171 Kuwait cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 172 Target disease prevalence
Fig. 173 Key payers in Kuwait
Fig. 174 Rest of MEA cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 175 Key company categorization
Fig. 176 Company market share analysis, 2022
Fig. 177 Strategic framework